Drug Profile
Interferon alpha-2a
Alternative Names: Roferon-ALatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Roche
- Class Antineoplastics; Antivirals; Interferons
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Chronic myeloid leukaemia; Cutaneous T-cell lymphoma; Hairy cell leukaemia; Hepatitis C; Kaposi's sarcoma; Malignant melanoma; Non-Hodgkin's lymphoma; Renal cell carcinoma
Most Recent Events
- 01 Oct 2007 Withdrawn for Chronic myeloid leukaemia in USA (unspecified route)
- 01 Oct 2007 Withdrawn for Hairy cell leukaemia in USA (unspecified route)
- 01 Oct 2007 Withdrawn for Hepatitis C in USA (unspecified route)